Compare EW & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EW | KB |
|---|---|---|
| Founded | 1958 | 2008 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.9B | 44.6B |
| IPO Year | 1999 | 2008 |
| Metric | EW | KB |
|---|---|---|
| Price | $86.44 | $126.72 |
| Analyst Decision | Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $96.37 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 127.2K |
| Earning Date | 04-23-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $6,067,600,000.00 | N/A |
| Revenue This Year | $13.39 | $18.22 |
| Revenue Next Year | $9.81 | $3.21 |
| P/E Ratio | $80.12 | ★ $9.90 |
| Revenue Growth | ★ 11.55 | N/A |
| 52 Week Low | $72.30 | $77.44 |
| 52 Week High | $96.29 | $133.29 |
| Indicator | EW | KB |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 52.66 |
| Support Level | $83.49 | $112.97 |
| Resistance Level | $89.28 | $133.19 |
| Average True Range (ATR) | 2.05 | 2.13 |
| MACD | -0.10 | -0.71 |
| Stochastic Oscillator | 49.06 | 40.72 |
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.